Valtecne S.p.A. (IT:VLT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Valtecne S.p.A. has reported a revenue of €24 million for the first nine months of 2024, marking a 0.5% increase from the previous year. The company’s medical business line has grown by 18%, now accounting for nearly 70% of total revenues, reflecting a strategic focus on the burgeoning medical sector.
For further insights into IT:VLT stock, check out TipRanks’ Stock Analysis page.